Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Daily News

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

L.A. McKeown

March 04, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

Presentation TCT Abstracts Posters 2019

Combination of Preoperative Frailty Status and Cardiac Biomarkers for Improving Risk Stratification in TAVR

Presenter: Francisco Romeo

October 02, 2019

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Daily News

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Yael L. Maxwell

July 24, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

Advertisement

February 2024 Dispatch for the CV Team

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

January 2022 News Roundup

March 2021 News Roundup

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Combination of Preoperative Frailty Status and Cardiac Biomarkers for Improving Risk Stratification in TAVR

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

Post-TAVR Myocardial Injury Linked to Mortality

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

PARTNER Analyses Highlight Mortality Curves After TAVR

Tumor Marker Predicts TAVR Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content